Cargando…

High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma

OBJECTIVES: Nectins are a new class of cell-adhesion molecules that play an important role in tumorigenesis and disease progression. The aim of this study was to investigate the prognostic and pathogenetic roles of nectins in hepatocellular carcinoma (HCC). METHODS: The expression levels of the nect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xuequan, Xing, Ziming, Chen, Huazhong, Yang, Haihua, Wang, Qiupeng, Xing, Tongjing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433868/ https://www.ncbi.nlm.nih.gov/pubmed/36059705 http://dx.doi.org/10.3389/fonc.2022.953529

Ejemplares similares

Corrigendum: High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma
por: Wang, Xuequan, et al.
Publicado: (2023)

Development and validation of epithelial mesenchymal transition-related prognostic model for hepatocellular carcinoma
por: Wang, Xuequan, et al.
Publicado: (2021)

MMP16 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma
por: Shen, Zhenghai, et al.
Publicado: (2017)

GPBAR1 is associated with asynchronous bone metastasis and poor prognosis of hepatocellular carcinoma
por: Chen, Nan, et al.
Publicado: (2023)

Nectin expression in pancreatic adenocarcinoma: nectin-3 is associated with a poor prognosis
por: Izumi, Hideki, et al.
Publicado: (2015)

Up-Regulation of hsa-miR-210 Promotes Venous Metastasis and Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Ji, Jia, et al.
Publicado: (2018)

Increased ATG5 Expression Predicts Poor Prognosis and Promotes EMT in Cervical Carcinoma
por: Zhou, Suna, et al.
Publicado: (2021)

Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma
por: Lei, Xiong, et al.
Publicado: (2015)

Corrigendum: Increased ATG5 Expression Predicts Poor Prognosis and Promotes EMT in Cervical Carcinoma
por: Zhou, Suna, et al.
Publicado: (2022)

Overexpression of POLA2 in hepatocellular carcinoma is involved in immune infiltration and predicts a poor prognosis
por: Liu, Long, et al.
Publicado: (2023)

CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients
por: Yao, Yang, et al.
Publicado: (2019)

CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma
por: Jiang, Guoqing, et al.
Publicado: (2016)

Identification of CFHR4 associated with poor prognosis of hepatocellular carcinoma
por: Ding, Qinglin, et al.
Publicado: (2022)

Circulating Tumor-Cell-Associated White Blood Cell Clusters in Peripheral Blood Indicate Poor Prognosis in Patients With Hepatocellular Carcinoma
por: Luo, Qiong, et al.
Publicado: (2020)

Identification and validation of a potential key gene SGOL1 for poor prognosis in hepatocellular carcinoma based on a bioinformatics approach
por: Fei, Xiaobin, et al.
Publicado: (2022)

Construction and validation of a prognostic model for hepatocellular carcinoma: Inflammatory ferroptosis and mitochondrial metabolism indicate a poor prognosis
por: Han, Fang, et al.
Publicado: (2023)

Over-expression of Nectin-4 promotes progression of esophageal cancer and correlates with poor prognosis of the patients
por: Deng, Haifeng, et al.
Publicado: (2019)

Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Kainan, et al.
Publicado: (2021)

Effect of portal vein thrombosis on the prognosis of patients with cirrhosis without a liver transplant: A systematic review and meta-analysis
por: Xian, Jianchun, et al.
Publicado: (2021)

FLVCR1 Predicts Poor Prognosis and Promotes Malignant Phenotype in Esophageal Squamous Cell Carcinoma via Upregulating CSE1L
por: Zhou, Suna, et al.
Publicado: (2021)

Expression and clinical significance of Nectin-4 in hepatocellular carcinoma
por: Ma, Jie, et al.
Publicado: (2016)

PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma
por: Liu, Wei-Ren, et al.
Publicado: (2014)

Prognostic value of nectin-4 in human cancers: A meta-analysis
por: Liu, Rongqiang, et al.
Publicado: (2023)

Corrigendum: Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Kainan, et al.
Publicado: (2021)

RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma
por: Wang, Wei, et al.
Publicado: (2017)

CircRNA-100338 Is Associated With mTOR Signaling Pathway and Poor Prognosis in Hepatocellular Carcinoma
por: Huang, Xiu-Yan, et al.
Publicado: (2019)

DDX39 Overexpression Predicts a Poor Prognosis and Promotes Aggressiveness of Melanoma by Cooperating With SNAIL
por: Xing, Chengjuan, et al.
Publicado: (2020)

UBE2I promotes metastasis and correlates with poor prognosis in hepatocellular carcinoma
por: Yang, Hao, et al.
Publicado: (2020)

SKA1/2/3 is a biomarker of poor prognosis in human hepatocellular carcinoma
por: Song, Guo-Qiang, et al.
Publicado: (2022)

MicroRNA-483-5p Predicts Poor Prognosis and Promotes Cancer Metastasis by Targeting EGR3 in Nasopharyngeal Carcinoma
por: Li, Xi-Zhao, et al.
Publicado: (2021)

Correlation and Survival Analysis of Distant Metastasis Site and Prognosis in Patients With Hepatocellular Carcinoma
por: Zhan, Hao, et al.
Publicado: (2021)

The Landscape of Immune Cells Indicates Prognosis and Applicability of Checkpoint Therapy in Hepatocellular Carcinoma
por: Huang, Jiacheng, et al.
Publicado: (2021)

Elevated Small Nuclear Ribonucleoprotein Polypeptide an Expression Correlated With Poor Prognosis and Immune Infiltrates in Patients With Hepatocellular Carcinoma
por: Zhang, Youfu, et al.
Publicado: (2022)

RNF135 Promoter Methylation Is Associated With Immune Infiltration and Prognosis in Hepatocellular Carcinoma
por: Wang, Xiao, et al.
Publicado: (2022)

Personalized quantitative models of NAD metabolism in hepatocellular carcinoma identify a subgroup with poor prognosis
por: Chedere, Adithya, et al.
Publicado: (2022)

Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma
por: Wang, Zhendong, et al.
Publicado: (2021)

FTH1 indicates poor prognosis and promotes metastasis in head and neck squamous cell carcinoma
por: Liao, Qingyun, et al.
Publicado: (2023)

CDC27-ODC1 Axis Promotes Metastasis, Accelerates Ferroptosis and Predicts Poor Prognosis in Neuroblastoma
por: Qiu, Lin, et al.
Publicado: (2022)

Deregulated bile acids may drive hepatocellular carcinoma metastasis by inducing an immunosuppressive microenvironment
por: Xia, Jin-kun, et al.
Publicado: (2022)

High Carbohydrate Antigen 19-9 Levels Indicate Poor Prognosis of Upper Tract Urothelial Carcinoma
por: Jeong, Seung-hwan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dfll2ujq6h42vmqla0os1p3lb7